Target Price | $32.42 |
Price | $27.84 |
Potential | 16.44% |
Number of Estimates | 24 |
24 Analysts have issued a price target CSX 2026 . The average CSX target price is $32.42. This is 16.44% higher than the current stock price. The highest price target is $38.00 36.49% , the lowest is $27.00 3.02% . | |
A rating was issued by 29 analysts: 20 Analysts recommend CSX to buy, 9 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CSX stock has an average upside potential 2026 of 16.44% . Most analysts recommend the CSX stock at Purchase. |
21 Analysts have issued a sales forecast CSX 2025 . The average CSX sales estimate is $14.3b . This is 0.01% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $14.6b 2.52% , the lowest is $13.8b 3.38% .
This results in the following potential growth metrics:
2024 | $14.5b | 0.80% |
---|---|---|
2025 | $14.3b | 1.79% |
2026 | $14.9b | 4.57% |
2027 | $15.4b | 3.42% |
2028 | $16.4b | 6.43% |
2029 | $17.3b | 5.20% |
22 Analysts have issued an CSX EBITDA forecast 2025. The average CSX EBITDA estimate is $6.6b . This is 1.99% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $6.9b 3.34% , the lowest is $6.3b 6.60% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $7.1b | 0.72% |
---|---|---|
2025 | $6.6b | 6.70% |
2026 | $7.2b | 8.72% |
2027 | $7.5b | 4.70% |
2028 | $7.9b | 5.27% |
2029 | $8.4b | 6.53% |
2024 | 48.50% | 0.08% |
---|---|---|
2025 | 46.07% | 5.01% |
2026 | 47.90% | 3.97% |
2027 | 48.49% | 1.23% |
2028 | 47.97% | 1.07% |
2029 | 48.57% | 1.25% |
16 CSX Analysts have issued a net profit forecast 2025. The average CSX net profit estimate is $3.1b . This is 1.32% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.3b 4.17% , the lowest is $2.9b 7.74% .
This results in the following potential growth metrics and future Net Margins:
2024 | $3.4b | 1.65% |
---|---|---|
2025 | $3.1b | 7.38% |
2026 | $3.7b | 17.20% |
2027 | $3.9b | 7.60% |
2028 | $4.4b | 12.75% |
2029 | $5.1b | 15.85% |
2024 | 23.13% | 0.86% |
---|---|---|
2025 | 21.81% | 5.69% |
2026 | 24.44% | 12.06% |
2027 | 25.43% | 4.05% |
2028 | 26.94% | 5.94% |
2029 | 29.67% | 10.13% |
16 Analysts have issued a CSX forecast for earnings per share. The average CSX EPS is $1.66 . This is 1.19% lower than earnings per share in the financial year 2024. The highest EPS forecast is $1.75 4.17% , the lowest is $1.55 7.74% .
This results in the following potential growth metrics and future valuations:
2024 | $1.79 | 1.65% |
---|---|---|
2025 | $1.66 | 7.26% |
2026 | $1.94 | 16.87% |
2027 | $2.09 | 7.73% |
2028 | $2.36 | 12.92% |
2029 | $2.73 | 15.68% |
Current | 16.59 | 12.08% |
---|---|---|
2025 | 16.79 | 1.21% |
2026 | 14.33 | 14.65% |
2027 | 13.32 | 7.05% |
2028 | 11.81 | 11.34% |
2029 | 10.19 | 13.72% |
Based on analysts' sales estimates for 2025, the CSX stock is valued at an EV/Sales of 4.96 and an P/S ratio of 3.66 .
This results in the following potential growth metrics and future valuations:
Current | 4.96 | 14.48% |
---|---|---|
2025 | 4.96 | 0.08% |
2026 | 4.74 | 4.37% |
2027 | 4.58 | 3.30% |
2028 | 4.31 | 6.04% |
2029 | 4.09 | 4.94% |
Current | 3.66 | 20.36% |
---|---|---|
2025 | 3.66 | 0.01% |
2026 | 3.50 | 4.37% |
2027 | 3.39 | 3.31% |
2028 | 3.18 | 6.04% |
2029 | 3.02 | 4.94% |
Analyst | Rating | Action | Date |
---|---|---|---|
B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Apr 17 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Apr 17 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Raymond James |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 17 2025 |
Analyst Rating | Date |
---|---|
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Apr 17 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Apr 17 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 17 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.